Product Name

  • Name

    Melatonine

  • EINECS 200-797-7
  • CAS No. 73-31-4
  • Article Data68
  • CAS DataBase
  • Density 1.175 g/cm3
  • Solubility
  • Melting Point 116.5-118 °C(lit.)
  • Formula C13H16N2O2
  • Boiling Point 512.831 °C at 760 mmHg
  • Molecular Weight 232.282
  • Flash Point 263.951 °C
  • Transport Information
  • Appearance Off-white powder
  • Safety 24/25-99-53-45
  • Risk Codes 60
  • Molecular Structure Molecular Structure of 73-31-4 (Melatonine)
  • Hazard Symbols ToxicT
  • Synonyms N-(2-(5-Methoxy-1H-indol-3-yl)ethyl)acetamide;N-Acetyl-5-methoxytryptamine;5-Methoxy-N-acetyltryptamine;Acetamide, N-(2-(5-methoxyindol-3-yl)ethyl)-;acetamide, N-[2-(5-methoxy-1H-indol-3-yl)ethyl]-;N-(2-(5-Methoxyindol-3-yl)ethyl)acetamide;Acetamide, N-[2-(5-methoxyindol-3-yl)ethyl]- (6CI,8CI);Melovine;Acetamide, N-[2- (5-methoxy-1H-indol-3-yl)ethyl]-;Melatonin;Acetamide, {N-[2-(5-methoxyindol-3-yl)ethyl]-};Circadin;Acetamide,N-[2-(5-methoxy-1H-indol-3-yl)- ethyl]-;Prestwick_312;Acetamide, N-[2-(5-methoxy-1H-indol-3-yl)ethyl]- (9CI);Melatonin (MLT);
  • PSA 54.12000
  • LogP 2.24600

Synthetic route

2-(5-methoxyindol-3-yl)ethylamine
608-07-1

2-(5-methoxyindol-3-yl)ethylamine

acetic anhydride
108-24-7

acetic anhydride

5-methoxy-N-acetyl-tryptamine
73-31-4

5-methoxy-N-acetyl-tryptamine

Conditions
ConditionsYield
With pyridine In dichloromethane100%
In 1,2-dichloro-ethane at 0℃; for 1h;96%
With triethylamine95%
2-(5-methoxyindol-3-yl)ethylamine
608-07-1

2-(5-methoxyindol-3-yl)ethylamine

acetyl chloride
75-36-5

acetyl chloride

5-methoxy-N-acetyl-tryptamine
73-31-4

5-methoxy-N-acetyl-tryptamine

Conditions
ConditionsYield
In dichloromethane at 25 - 30℃; Temperature;98.3%
With triethylamine In dichloromethane at 20℃;
With triethylamine In dichloromethane at 0 - 20℃; for 5h;
2-(5-methoxyindol-3-yl)ethylamine
608-07-1

2-(5-methoxyindol-3-yl)ethylamine

potassium thioacetate
10387-40-3

potassium thioacetate

5-methoxy-N-acetyl-tryptamine
73-31-4

5-methoxy-N-acetyl-tryptamine

Conditions
ConditionsYield
With tetrabutylammonium tetrafluoroborate In ethyl acetate at 20℃; Electrochemical reaction;97%
2-(5-methoxyindol-3-yl)ethylamine
608-07-1

2-(5-methoxyindol-3-yl)ethylamine

1,3-diacetyl-1,3-dihydro-benzoimidazol-2-one
2735-73-1

1,3-diacetyl-1,3-dihydro-benzoimidazol-2-one

5-methoxy-N-acetyl-tryptamine
73-31-4

5-methoxy-N-acetyl-tryptamine

Conditions
ConditionsYield
In tetrahydrofuran at 20℃; for 0.3h;93%
N-[2-(1-benzyl-5-methoxy-1H-indol-3-yl)ethyl]acetamide

N-[2-(1-benzyl-5-methoxy-1H-indol-3-yl)ethyl]acetamide

5-methoxy-N-acetyl-tryptamine
73-31-4

5-methoxy-N-acetyl-tryptamine

Conditions
ConditionsYield
With ammonia; sodium In tetrahydrofuran at -78 - -33℃; for 1h;92%
vinyl acetate
108-05-4

vinyl acetate

2-(5-methoxyindol-3-yl)ethylamine
608-07-1

2-(5-methoxyindol-3-yl)ethylamine

5-methoxy-N-acetyl-tryptamine
73-31-4

5-methoxy-N-acetyl-tryptamine

Conditions
ConditionsYield
With agarose immobilized acetyltransferase from Mycobacterium smegmatis (MsAcT) In aq. phosphate buffer; dimethyl sulfoxide at 25℃; under 760.051 Torr; for 0.0833333h; pH=8.0; Flow reactor; Enzymatic reaction;92%
2-(5-methoxyindol-3-yl)ethylamine
608-07-1

2-(5-methoxyindol-3-yl)ethylamine

thioacetic acid
507-09-5

thioacetic acid

5-methoxy-N-acetyl-tryptamine
73-31-4

5-methoxy-N-acetyl-tryptamine

Conditions
ConditionsYield
With 10-methyl-9-(2,4,6-trimethylphenyl) acridinium tetrafluoroborate In acetonitrile at 20℃; for 5h; Irradiation;92%
N-(2-{5-methoxy-1-[(4-methylphenyl)sulfonyl]-1H-indol-3-yl}ethyl)acetamide
1020701-51-2

N-(2-{5-methoxy-1-[(4-methylphenyl)sulfonyl]-1H-indol-3-yl}ethyl)acetamide

5-methoxy-N-acetyl-tryptamine
73-31-4

5-methoxy-N-acetyl-tryptamine

Conditions
ConditionsYield
With tetraethylammonium perchlorate; triethylamine In dimethyl sulfoxide at 20℃; for 10h; Electrolysis; Green chemistry;92%
With 3,6‐di‐tert‐butyl‐9‐mesityl‐10‐phenylacridin‐10‐ium tetrafluoroborate; N-ethyl-N,N-diisopropylamine In water; acetonitrile for 20h; Irradiation;81%
5-methoxytryptamine hydrochloride
66-83-1

5-methoxytryptamine hydrochloride

acetic anhydride
108-24-7

acetic anhydride

5-methoxy-N-acetyl-tryptamine
73-31-4

5-methoxy-N-acetyl-tryptamine

Conditions
ConditionsYield
With triethylamine In dichloromethane at 0 - 25℃; for 3h;90%
boron trifluoride methanol complex
16045-88-8, 373-57-9

boron trifluoride methanol complex

Nb-acetyl-1-hydroxytriptamine
136788-90-4

Nb-acetyl-1-hydroxytriptamine

5-methoxy-N-acetyl-tryptamine
73-31-4

5-methoxy-N-acetyl-tryptamine

Conditions
ConditionsYield
In methanol Heating;80%
methanol
67-56-1

methanol

Nb-acetyl-1-hydroxytriptamine
136788-90-4

Nb-acetyl-1-hydroxytriptamine

A

bufotenin
487-93-4

bufotenin

B

5-methoxy-N-acetyl-tryptamine
73-31-4

5-methoxy-N-acetyl-tryptamine

Conditions
ConditionsYield
With sulfuric acid Heating;A 7%
B 80%
methanol
67-56-1

methanol

Nb-acetyl-1-hydroxytriptamine
136788-90-4

Nb-acetyl-1-hydroxytriptamine

A

N-Acetyltryptamine
1016-47-3

N-Acetyltryptamine

B

5-methoxy-N-acetyl-tryptamine
73-31-4

5-methoxy-N-acetyl-tryptamine

Conditions
ConditionsYield
With boron trifluoride for 0.666667h; Product distribution; Further Variations:; Reagents; Temperatures; reaction times; Elimination; methoxylation; Heating;A 5%
B 80%
5-methoxylindole
1006-94-6

5-methoxylindole

2-acetylaminoethanol
142-26-7

2-acetylaminoethanol

5-methoxy-N-acetyl-tryptamine
73-31-4

5-methoxy-N-acetyl-tryptamine

Conditions
ConditionsYield
With dichloro(pentamethylcyclopentadienyl) iridium; caesium carbonate at 150℃; for 48h; Inert atmosphere; Sealed tube;78%
N-[(methyl)carbonyl]-2-pyrroline
23105-58-0

N-[(methyl)carbonyl]-2-pyrroline

4-methoxyphenylhydrazine hydrochloride
19501-58-7

4-methoxyphenylhydrazine hydrochloride

5-methoxy-N-acetyl-tryptamine
73-31-4

5-methoxy-N-acetyl-tryptamine

Conditions
ConditionsYield
In ethanol; water; acetic acid for 0.333333h; Cyclization; Fischer synthesis; Heating;75%
N-[2-(1-methanesulfonyl-5-methoxy-2,3-dihydro-1H-indol-3-yl)-ethyl]-acetamide
474640-48-7

N-[2-(1-methanesulfonyl-5-methoxy-2,3-dihydro-1H-indol-3-yl)-ethyl]-acetamide

5-methoxy-N-acetyl-tryptamine
73-31-4

5-methoxy-N-acetyl-tryptamine

Conditions
ConditionsYield
With sulfuric acid at 0℃; for 0.5h;72%
2-(5-methoxyindol-3-yl)ethylamine
608-07-1

2-(5-methoxyindol-3-yl)ethylamine

ethyl acetate
141-78-6

ethyl acetate

5-methoxy-N-acetyl-tryptamine
73-31-4

5-methoxy-N-acetyl-tryptamine

Conditions
ConditionsYield
With acetic acid at 80℃; for 20h; Sealed tube;70%
With agarose immobilized acetyltransferase from Mycobacterium smegmatis (MsAcT) In aq. phosphate buffer; dimethyl sulfoxide at 25℃; under 760.051 Torr; for 0.0833333h; pH=8.0; Flow reactor; Enzymatic reaction;
N-acetyl-5-hydroxytryptamine
1210-83-9

N-acetyl-5-hydroxytryptamine

dimethyl sulfate
77-78-1

dimethyl sulfate

5-methoxy-N-acetyl-tryptamine
73-31-4

5-methoxy-N-acetyl-tryptamine

Conditions
ConditionsYield
With sodium hydroxide In water at 26℃; for 2.25h;61.4%
2-(2,4-dinitrophenylsulfenyl)melatonin
28772-49-8

2-(2,4-dinitrophenylsulfenyl)melatonin

5-methoxy-N-acetyl-tryptamine
73-31-4

5-methoxy-N-acetyl-tryptamine

Conditions
ConditionsYield
With nickel In 1,4-dioxane; water at 80 - 90℃; for 20h; until it lost its coloration;54%
N-allylacetamide
692-33-1

N-allylacetamide

carbon monoxide
201230-82-2

carbon monoxide

4-methoxyphenylhydrazine hydrochloride
19501-58-7

4-methoxyphenylhydrazine hydrochloride

5-methoxy-N-acetyl-tryptamine
73-31-4

5-methoxy-N-acetyl-tryptamine

Conditions
ConditionsYield
Stage #1: N-allylacetamide; carbon monoxide With hydrogen; acetylacetonatodicarbonylrhodium(l); 4,5-bis(diphenylphos4,5-bis(diphenylphosphino)-9,9-dimethylxanthenephino)-9,9-dimethylxanthene In water; toluene at 70℃; under 7500.75 Torr; for 30h; Hydroformylation;
Stage #2: 4-methoxyphenylhydrazine hydrochloride Condensation;
Stage #3: With acetic acid for 0.166667h; Cyclization; Fischer indole reaction; Heating; Further stages.;
44%
4-methoxyphenylhydrazine hydrochloride
19501-58-7

4-methoxyphenylhydrazine hydrochloride

1-acetyl-2-methoxypyrrolidine
63050-21-5

1-acetyl-2-methoxypyrrolidine

5-methoxy-N-acetyl-tryptamine
73-31-4

5-methoxy-N-acetyl-tryptamine

Conditions
ConditionsYield
In water; acetic acid Heating;32%
indole
120-72-9

indole

Nb-acetyl-1-methoxytryptamine
180910-62-7

Nb-acetyl-1-methoxytryptamine

A

5-methoxy-N-acetyl-tryptamine
73-31-4

5-methoxy-N-acetyl-tryptamine

B

N-[2-(5-methoxy-1'H-[1,3']biindolyl-3-yl)-ethyl]-acetamide

N-[2-(5-methoxy-1'H-[1,3']biindolyl-3-yl)-ethyl]-acetamide

C

N-[2-(5'-methoxy-1H,1'H-[3,4']biindolyl-3'-yl)-ethyl]-acetamide

N-[2-(5'-methoxy-1H,1'H-[3,4']biindolyl-3'-yl)-ethyl]-acetamide

D

N-[2-(5'-methoxy-1H,1'H-[3,7']biindolyl-3'-yl)-ethyl]-acetamide

N-[2-(5'-methoxy-1H,1'H-[3,7']biindolyl-3'-yl)-ethyl]-acetamide

Conditions
ConditionsYield
With methanesulfonyl chloride; triethylamine In chloroform Further byproducts given;A 7%
B 7%
C 12%
D 7%
5-methoxyindole-3-acetonitrile
2436-17-1

5-methoxyindole-3-acetonitrile

5-methoxy-N-acetyl-tryptamine
73-31-4

5-methoxy-N-acetyl-tryptamine

Conditions
ConditionsYield
With ethanol; sodium Erwaermen des Reaktionsprodukts mit Essigsaeure und Acetanhydrid auf 100grad;
Nb,Nb-diacetyl-5-methoxytryptamine
188396-98-7

Nb,Nb-diacetyl-5-methoxytryptamine

5-methoxy-N-acetyl-tryptamine
73-31-4

5-methoxy-N-acetyl-tryptamine

Conditions
ConditionsYield
With ammonium hydroxide In methanol Yield given;
(E)-3-(2-nitroethenyl)-5-methoxyindole
61675-19-2

(E)-3-(2-nitroethenyl)-5-methoxyindole

acetic anhydride
108-24-7

acetic anhydride

A

5-methoxy-N-acetyl-tryptamine
73-31-4

5-methoxy-N-acetyl-tryptamine

B

(E)-N-[2-(5-methoxy-1H-indol-3-yl)etenyl]acetamide

(E)-N-[2-(5-methoxy-1H-indol-3-yl)etenyl]acetamide

C

N-[(E)-2-(1-Acetyl-5-methoxy-1H-indol-3-yl)-vinyl]-acetamide

N-[(E)-2-(1-Acetyl-5-methoxy-1H-indol-3-yl)-vinyl]-acetamide

Conditions
ConditionsYield
With hydrogen; nickel In tetrahydrofuran under 3040 Torr; for 10h; Ambient temperature;
With sodium hydroxide; hydrogen; nickel 1.) THF, RT, 4 atm, 10 h, 2.) MeOH, RT, 4h; Yield given;
4-aminobutyraldehyde dimethyl acetal
19060-15-2

4-aminobutyraldehyde dimethyl acetal

4-methoxyphenylhydrazine hydrochloride
19501-58-7

4-methoxyphenylhydrazine hydrochloride

acetic anhydride
108-24-7

acetic anhydride

5-methoxy-N-acetyl-tryptamine
73-31-4

5-methoxy-N-acetyl-tryptamine

Conditions
ConditionsYield
1.) 5 - 10 deg C, 1 h, 2.) AcOH, EtOH, H2O, 40 deg C, 12 h; Yield given; Multistep reaction;
5-methoxytryptamine hydrochloride
66-83-1

5-methoxytryptamine hydrochloride

[14C]acetyl-CoA

[14C]acetyl-CoA

5-methoxy-N-acetyl-tryptamine
73-31-4

5-methoxy-N-acetyl-tryptamine

Conditions
ConditionsYield
With sheep pineal supernatant (serotonin-N-acetyl transferase); Pargyline In phosphate buffer at 37℃; for 0.166667h; pH=6.8; Enzyme kinetics;
acetic anhydride
108-24-7

acetic anhydride

3-(2-isocyanato-ethyl)-5-methoxy-1H-indole

3-(2-isocyanato-ethyl)-5-methoxy-1H-indole

5-methoxy-N-acetyl-tryptamine
73-31-4

5-methoxy-N-acetyl-tryptamine

Conditions
ConditionsYield
Stage #1: acetic anhydride; 3-(2-isocyanato-ethyl)-5-methoxy-1H-indole In acetic acid Heating;
Stage #2: With potassium carbonate In methanol at 20℃; Further stages.;
acetic anhydride
108-24-7

acetic anhydride

3-(2-isocyanato-ethyl)-5-methoxy-1H-indole

3-(2-isocyanato-ethyl)-5-methoxy-1H-indole

A

5-methoxy-N-acetyl-tryptamine
73-31-4

5-methoxy-N-acetyl-tryptamine

B

N-(2-(1-acetyl-5-methoxy-1H-indol-3-yl)ethyl)acetamide

N-(2-(1-acetyl-5-methoxy-1H-indol-3-yl)ethyl)acetamide

Conditions
ConditionsYield
In acetic acid Heating; Title compound not separated from byproducts.;
N-[2-(5-methoxy-1-nitroso-1H-indol-3-yl)ethyl]acetamide

N-[2-(5-methoxy-1-nitroso-1H-indol-3-yl)ethyl]acetamide

5-methoxy-N-acetyl-tryptamine
73-31-4

5-methoxy-N-acetyl-tryptamine

Conditions
ConditionsYield
With Tris-HCl buffer In ethanol; water at 37℃; pH=7.40; Kinetics; Further Variations:; pH-values; Reagents; Solvents;
With Tris-HCl buffer; L-Cysteine In ethanol; water at 37℃; pH=7.40; Kinetics; Further Variations:; pH-values; Reagents;
5-methoxy-N-acetyl-tryptamine
73-31-4

5-methoxy-N-acetyl-tryptamine

N-(2-(5-methoxy-1H-indol-3-yl-2,4,6-d3)ethyl)acetamide

N-(2-(5-methoxy-1H-indol-3-yl-2,4,6-d3)ethyl)acetamide

Conditions
ConditionsYield
With perchloric acid; d(4)-methanol at 75℃; for 24h; Inert atmosphere;100%
With tris(pentafluorophenyl)borate; water-d2 In chloroform-d1 at 80℃; for 24h; Sealed tube; regioselective reaction;95%
5-methoxy-N-acetyl-tryptamine
73-31-4

5-methoxy-N-acetyl-tryptamine

2-iodomelatonin

2-iodomelatonin

Conditions
ConditionsYield
With Iodine monochloride In dichloromethane at 20℃; for 8h; Inert atmosphere;98%
With chloroamine-T; potassium iodide In chloroform for 0.0833333h;87%
With iodine; silver trifluoromethanesulfonate In tetrahydrofuran at 20℃; for 0.333333h;46%
2-bromo-pyridine
109-04-6

2-bromo-pyridine

5-methoxy-N-acetyl-tryptamine
73-31-4

5-methoxy-N-acetyl-tryptamine

N-(2-(5-methoxy-1-(pyridin-2-yl)-1H-indol-3-yl)ethyl)acetamide

N-(2-(5-methoxy-1-(pyridin-2-yl)-1H-indol-3-yl)ethyl)acetamide

Conditions
ConditionsYield
With potassium phosphate; copper(l) iodide; N,N`-dimethylethylenediamine In toluene at 120℃; for 20h; Inert atmosphere;98%
di-tert-butyl dicarbonate
24424-99-5

di-tert-butyl dicarbonate

5-methoxy-N-acetyl-tryptamine
73-31-4

5-methoxy-N-acetyl-tryptamine

N-[2-(1-tert-butoxycarbonyl-5-methoxy-1H-indol-3-yl)ethyl]acetamide
431074-74-7

N-[2-(1-tert-butoxycarbonyl-5-methoxy-1H-indol-3-yl)ethyl]acetamide

Conditions
ConditionsYield
With dmap In acetonitrile at 25℃; for 16h;95%
Stage #1: 5-methoxy-N-acetyl-tryptamine With sodium hydroxide; tetra(n-butyl)ammonium hydrogensulfate In dichloromethane at 0℃; for 0.5h;
Stage #2: di-tert-butyl dicarbonate In dichloromethane at 0℃; for 1h; Further stages.;
80%
With dmap In tetrahydrofuran70%
Stage #1: 5-methoxy-N-acetyl-tryptamine With tetra(n-butyl)ammonium hydrogensulfate; sodium hydroxide In dichloromethane at 20℃; for 0.0833333h; Inert atmosphere;
Stage #2: di-tert-butyl dicarbonate In dichloromethane at 20℃; for 5h; Inert atmosphere;
1.13 g
N-(phenylthio)succinimide
14204-24-1

N-(phenylthio)succinimide

5-methoxy-N-acetyl-tryptamine
73-31-4

5-methoxy-N-acetyl-tryptamine

N-(2-(5-methoxy-2-(phenylthio)-1H-indol-3-yl)ethyl)acetamide

N-(2-(5-methoxy-2-(phenylthio)-1H-indol-3-yl)ethyl)acetamide

Conditions
ConditionsYield
With 2-((-2-(3-(3,5-bis(trifluoromethyl)phenyl)thioureido)cyclohexyl)carbamoyl)-3,4,5,6-tetrachlorobenzoic acid; trifluoroacetic acid In methanol; dichloromethane; water at 20℃; for 24h;95%
5-methoxy-N-acetyl-tryptamine
73-31-4

5-methoxy-N-acetyl-tryptamine

chloroformic acid ethyl ester
541-41-3

chloroformic acid ethyl ester

3-(2-acetylamino-ethyl)-5-methoxy-indole-1-carboxylic acid ethyl ester
519186-54-0

3-(2-acetylamino-ethyl)-5-methoxy-indole-1-carboxylic acid ethyl ester

Conditions
ConditionsYield
With sodium hydroxide; tetra(n-butyl)ammonium hydrogensulfate In dichloromethane at 20℃; for 1h;93%
5-methoxy-N-acetyl-tryptamine
73-31-4

5-methoxy-N-acetyl-tryptamine

iodoundecafluorocyclohexane
355-69-1

iodoundecafluorocyclohexane

N-(2-(5-methoxy-2-(perfluorocyclohexyl)-1H-indol-3-yl)ethyl)acetamide

N-(2-(5-methoxy-2-(perfluorocyclohexyl)-1H-indol-3-yl)ethyl)acetamide

Conditions
ConditionsYield
With palladium diacetate; silver carbonate In 1,4-dioxane at 80℃; for 10h; Schlenk technique; Inert atmosphere; regioselective reaction;93%
formic acid
64-18-6

formic acid

5-methoxy-N-acetyl-tryptamine
73-31-4

5-methoxy-N-acetyl-tryptamine

Nb-acetyl-1-formyl-5-methoxytryptamine

Nb-acetyl-1-formyl-5-methoxytryptamine

Conditions
ConditionsYield
In water at 20℃; for 94h; Formylation;92%
Acylation;88%
5-methoxy-N-acetyl-tryptamine
73-31-4

5-methoxy-N-acetyl-tryptamine

acetic anhydride
108-24-7

acetic anhydride

Nb,Nb-diacetyl-5-methoxytryptamine
188396-98-7

Nb,Nb-diacetyl-5-methoxytryptamine

Conditions
ConditionsYield
for 2h; Acetylation; Heating;92%
2-phenyl-indole
948-65-2

2-phenyl-indole

5-methoxy-N-acetyl-tryptamine
73-31-4

5-methoxy-N-acetyl-tryptamine

N-(2-(5-methoxy-2-(3-oxo-2-phenylindolin-2-yl)-1H-indol-3-yl)ethyl)acetamide

N-(2-(5-methoxy-2-(3-oxo-2-phenylindolin-2-yl)-1H-indol-3-yl)ethyl)acetamide

Conditions
ConditionsYield
With C9H18NO(1+)*BH4(1-) In tetrahydrofuran at 0℃;92%
5-methoxy-N-acetyl-tryptamine
73-31-4

5-methoxy-N-acetyl-tryptamine

1-Bromo-2-bromomethyl-benzene
3433-80-5

1-Bromo-2-bromomethyl-benzene

N-propanoyl 2-[1-(2-bromobenzyl)-5-methoxyindol-3-yl]ethanamine

N-propanoyl 2-[1-(2-bromobenzyl)-5-methoxyindol-3-yl]ethanamine

Conditions
ConditionsYield
With sodium hydride In tetrahydrofuran at 20℃; for 3h; Condensation;91%
5-methoxy-N-acetyl-tryptamine
73-31-4

5-methoxy-N-acetyl-tryptamine

p-toluenesulfonyl chloride
98-59-9

p-toluenesulfonyl chloride

N-(2-{5-methoxy-1-[(4-methylphenyl)sulfonyl]-1H-indol-3-yl}ethyl)acetamide
1020701-51-2

N-(2-{5-methoxy-1-[(4-methylphenyl)sulfonyl]-1H-indol-3-yl}ethyl)acetamide

Conditions
ConditionsYield
Stage #1: 5-methoxy-N-acetyl-tryptamine With tetrabutylammomium bromide; sodium hydroxide In dichloromethane at 20℃; for 0.5h;
Stage #2: p-toluenesulfonyl chloride In dichloromethane at 20℃; for 6h;
90.5%
Stage #1: 5-methoxy-N-acetyl-tryptamine With sodium hydride In N,N-dimethyl-formamide at 0℃; Inert atmosphere;
Stage #2: p-toluenesulfonyl chloride In N,N-dimethyl-formamide at 0 - 20℃;
Stage #1: 5-methoxy-N-acetyl-tryptamine With tetra(n-butyl)ammonium hydrogensulfate; sodium hydroxide In dichloromethane at 20℃; for 0.0833333h; Inert atmosphere;
Stage #2: p-toluenesulfonyl chloride In dichloromethane at 20℃; for 5h; Inert atmosphere;
1.20 g
With tetra(n-butyl)ammonium hydrogensulfate; potassium hydroxide In dichloromethane at 0 - 20℃;
5-methoxy-N-acetyl-tryptamine
73-31-4

5-methoxy-N-acetyl-tryptamine

2-[131I]-iodo-melatonine

2-[131I]-iodo-melatonine

Conditions
ConditionsYield
With sodium hydroxide; [131I]-sodium iodide; chloroamine-T In chloroform for 0.05h;90%
diazoacetic acid ethyl ester
623-73-4

diazoacetic acid ethyl ester

5-methoxy-N-acetyl-tryptamine
73-31-4

5-methoxy-N-acetyl-tryptamine

ethyl (3-(2-(acetylamino)ethyl)-5-methoxy-1H-indol-2-yl)acetate

ethyl (3-(2-(acetylamino)ethyl)-5-methoxy-1H-indol-2-yl)acetate

Conditions
ConditionsYield
With tris(bipyridine)ruthenium(II) dichloride hexahydrate In methanol; dichloromethane; water Sealed tube; Irradiation; Cooling with ice; regioselective reaction;90%
5-methoxy-N-acetyl-tryptamine
73-31-4

5-methoxy-N-acetyl-tryptamine

trifluoroacetic anhydride
407-25-0

trifluoroacetic anhydride

Trifluoro-acetic acid (2S,3'S)-5-methoxy-2'-methylene-1,1'-bis-(2,2,2-trifluoro-acetyl)-1,2-dihydro-spiro[indole-3,3'-pyrrolidin]-2-yl ester
83345-85-1, 140427-20-9

Trifluoro-acetic acid (2S,3'S)-5-methoxy-2'-methylene-1,1'-bis-(2,2,2-trifluoro-acetyl)-1,2-dihydro-spiro[indole-3,3'-pyrrolidin]-2-yl ester

Conditions
ConditionsYield
In benzene at 5℃; for 0.166667h;89%
5-methoxy-N-acetyl-tryptamine
73-31-4

5-methoxy-N-acetyl-tryptamine

2-(5-methoxyindol-3-yl)ethylamine
608-07-1

2-(5-methoxyindol-3-yl)ethylamine

Conditions
ConditionsYield
With ammonium bromide; ethylenediamine at 100℃; for 7h; Microwave irradiation;89%
With sulfuric acid In water for 8h; Heating;69.7%
With sodium hydroxide In 2-methyl-propan-1-ol
5-methoxy-N-acetyl-tryptamine
73-31-4

5-methoxy-N-acetyl-tryptamine

benzenesulfonyl chloride
98-09-9

benzenesulfonyl chloride

N-[2-(1-benzenesulfonyl-5-methoxy-1H-indol-3-yl)ethyl]acetamide
296280-80-3

N-[2-(1-benzenesulfonyl-5-methoxy-1H-indol-3-yl)ethyl]acetamide

Conditions
ConditionsYield
Stage #1: 5-methoxy-N-acetyl-tryptamine With sodium hydroxide; tetra(n-butyl)ammonium hydrogensulfate In dichloromethane at 0℃; for 0.5h;
Stage #2: benzenesulfonyl chloride In dichloromethane at 0℃; for 1h; Further stages.;
88%
Stage #1: 5-methoxy-N-acetyl-tryptamine With sodium hydroxide; tetra-(n-butyl)ammonium iodide at 0℃; for 0.25h;
Stage #2: benzenesulfonyl chloride at 20℃; for 3.5h;
71%
With tetra(n-butyl)ammonium hydrogensulfate; sodium hydroxide
5-methoxy-N-acetyl-tryptamine
73-31-4

5-methoxy-N-acetyl-tryptamine

C13H28O4Si

C13H28O4Si

isovaleraldehyde
590-86-3

isovaleraldehyde

C25H38N2O6

C25H38N2O6

Conditions
ConditionsYield
With toluene-4-sulfonic acid In dichloromethane at 20℃; for 0.166667h; chemoselective reaction;88%
With toluene-4-sulfonic acid In dichloromethane at 20℃; for 0.166667h;88%
5-methoxy-N-acetyl-tryptamine
73-31-4

5-methoxy-N-acetyl-tryptamine

4-methoxy-3-(4-(2,2,2-trichloro-acetyl)piperazin-1-yl)benzene-1-sulfonylchloride
219963-60-7

4-methoxy-3-(4-(2,2,2-trichloro-acetyl)piperazin-1-yl)benzene-1-sulfonylchloride

N-(2-(5-methoxy-1-((4-methoxy-3-(4-(2,2,2-trichloroacetyl)piperazin-1-yl)phenyl)sulfonyl)-1H-indol-3-yl)ethyl)acetamide

N-(2-(5-methoxy-1-((4-methoxy-3-(4-(2,2,2-trichloroacetyl)piperazin-1-yl)phenyl)sulfonyl)-1H-indol-3-yl)ethyl)acetamide

Conditions
ConditionsYield
With sodium hydride In N,N-dimethyl-formamide; mineral oil at 0 - 25℃; for 2.16h;88%
5-methoxy-N-acetyl-tryptamine
73-31-4

5-methoxy-N-acetyl-tryptamine

O,O'-bis[(1S,2S,3S,5R)-2,6,6-trimethylbicyclo[3.1.1]-hept-3-yl]dithiophosphoric acid
1456553-31-3

O,O'-bis[(1S,2S,3S,5R)-2,6,6-trimethylbicyclo[3.1.1]-hept-3-yl]dithiophosphoric acid

C20H35O2PS2*C13H16N2O2

C20H35O2PS2*C13H16N2O2

Conditions
ConditionsYield
In ethanol at 20℃; for 1h; Inert atmosphere;88%
5-methoxy-N-acetyl-tryptamine
73-31-4

5-methoxy-N-acetyl-tryptamine

O,O-di[(–)-(1R,2S,5R)-2-isopropyl-5-methylcyclohex-1-yl] dithiophosphoric acid

O,O-di[(–)-(1R,2S,5R)-2-isopropyl-5-methylcyclohex-1-yl] dithiophosphoric acid

C20H39O2PS2*C13H16N2O2

C20H39O2PS2*C13H16N2O2

Conditions
ConditionsYield
In ethanol at 20℃; for 2h; Inert atmosphere;87%

Melatonine History

  Melatonin (CAS NO.73-31-4) is related to the mechanism by which some amphibians and reptiles change the color of their skin and, indeed, it was in this connection the substance first was discovered. McCord and Allen discovered (J Exptl Zool, 1917) that extract of the pineal glands of cows lightened frog skin, while Aaron B. Lerner is credited for naming the hormone and for defining its chemical structure in 1958. In the mid-70s Lynch et al. demonstrated that also in humans the production of melatonin exhibits a circadian rhythm.

Melatonine Specification

1. Introduction of Melatonine
Melatonine is one kind of white or off-white powder. The IUPAC name of this chemical is N-[2-(5-Methoxy-1H-indol-3-yl)ethyl]acetamide. Besides, Melatonine belongs to Heterocyclic Series; Heterocycles series; Indoles; Tryptamines; Nutritional Supplements; Intermediates & Fine Chemicals; Pharmaceuticals; Melatonin receptor. In addition, Melatonine Classification Code is Antioxidants; Central Nervous System Agents; Central Nervous System Depressants; Drug / Therapeutic Agent; Hormone; Mutation data; Protective Agents; Reproductive Effect; Tumor data.

What's more, Melatonine solubility in water is soluble0.1 mg/mL, in ethanol is soluble8 mg/mL. It is a naturally occurring hormone found in animals and in some other living organisms, including algae.

2. Properties of Melatonine
Physical properties about Melatonine are:
(1)Melting point: 116.5-118 °C(lit.); (2)Density: 1.175 g/cm3; (3)Flash Point: 264 °C ; (4)storage temp.: -15 °C; (5)Index of Refraction: 1.6; (6)Surface Tension: 46.6 dyne/cm; (7)Enthalpy of Vaporization: 78.41 kJ/mol; (8)Boiling Point: 512.8 °C at 760 mmHg; (9)Vapour Pressure: 1.25E-10 mmHg at 25 °C; (10)XLogP3: 0.8; (11)H-Bond Donor: 2; (12)H-Bond Acceptor: 2.

3. Structure Descriptors of Melatonine
(1)Canonical SMILES: CC(=O)NCCC1=CNC2=C1C=C(C=C2)OC
(2)InChI: InChI=1S/C13H16N2O2/c1-9(16)14-6-5-10-8-15-13-4-3-11(17-2)7-12(10)13/h3-4,7-8,15H,5-6H2,1-2H3,(H,14,16)
(3)InChIKey: DRLFMBDRBRZALE-UHFFFAOYSA-N
(4)Smiles: c12c([nH]cc1CCNC(C)=O)ccc(c2)OC

4. Toxicity of Melatonine

Organism Test Type Route Reported Dose (Normalized Dose) Effect Source
mouse LD50 intraperitoneal 1375mg/kg (1375mg/kg)   Pharmaceutical Chemistry Journal Vol. 17, Pg. 559, 1983.
mouse LD50 intravenous 180mg/kg (180mg/kg)   U.S. Army Armament Research & Development Command, Chemical Systems Laboratory, NIOSH Exchange Chemicals. Vol. NX#02739,
mouse LD50 oral 1250mg/kg (1250mg/kg)   Journal of Pharmacology and Experimental Therapeutics. Vol. 227, Pg. 587, 1983.
mouse LD50 subcutaneous > 1600mg/kg (1600mg/kg)   Journal of Pharmacology and Experimental Therapeutics. Vol. 227, Pg. 587, 1983.
rat LD50 intraperitoneal 1131mg/kg (1131mg/kg)   Journal of Pharmacology and Experimental Therapeutics. Vol. 227, Pg. 587, 1983.
rat LD50 intravenous 356mg/kg (356mg/kg)   Journal of Pharmacology and Experimental Therapeutics. Vol. 227, Pg. 587, 1983.
rat LD50 oral > 3200mg/kg (3200mg/kg)   Journal of Pharmacology and Experimental Therapeutics. Vol. 227, Pg. 587, 1983.
rat LD50 subcutaneous > 1600mg/kg (1600mg/kg)   Journal of Pharmacology and Experimental Therapeutics. Vol. 227, Pg. 587, 1983.

Melatonin (CAS NO.73-31-4) has a very low toxicity in rats. Rat maternal toxicity: the no observable adverse effect level (NOAEL) and lowest observed adverse effect level (LOAEL) were 100 and 200 mg/kg/day, respectively, and the developmental toxicity NOAEL was >= 200 mg/kg/day.

5. Safety information of Melatonine
Hazard Codes: Toxic
Risk Statements: 60 
R60: May impair fertility.
Safety Statements: 24/25
S24/25: Avoid contact with skin and eyes. 
WGK Germany: 2 
RTECS: AC5955000
F: 8-10-23

6. Uses of Melatonine
Melatonin (CAS NO.73-31-4) is important in the regulation of the circadian rhythms of several biological functions.The primary motivation for the use of melatonin as a supplement may be as a natural aid to better sleep. Many biological effects of melatonin are produced through activation of melatonin receptors, while others are due to its role as a pervasive and powerful antioxidant with a particular role in the protection of nuclear and mitochondrial DNA. Melatonin have been available as a dietary supplement.

Several clinical studies indicate that supplementation with melatonin is an effective preventive treatment for migraines and cluster headaches. It has been shown to be effective in treating one form of depression, seasonal affective disorder, and is being considered for bipolar and other disorders where circadian disturbances are involved. Melatonin is involved in the regulation of body weight, and may be helpful in treating obesity. Histologically, it is believed that melatonin has some effects for sexual development in higher organisms.

7. Production of Melatonin
Melatonin present in the pineal gland of the mammalian brain, the general method of the bovine brain pineal freeze-dried and pulverized into a powder, with petroleum ether and removal of fat, uniformly mixed into a slurry with deionized water, forafter centrifugation, the supernatant was taken with an equal volume of ethyl acetate extract, and the extract was dried in vacuo to give a white crude melatonin Collectibles then obtained after recrystallization.

Post buying leads

About|Contact|Cas|Product Name|Molecular|Country|Encyclopedia

Message|New Cas|MSDS|Service|Advertisement|CAS DataBase|Article Data|Manufacturers | Chemical Catalog

©2008 LookChem.com,License: ICP

NO.:Zhejiang16009103

complaints:service@lookchem.com Desktop View